RxDoctor Payments DataLook up a doctor →

David Cahn, MD

Urology · Golden, CONPI 1275561748

Payments from drug & device makers

$12,129,836in general payments, 2019–2025

Across 1,238 payments — averaging $9797.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$5.9M
  • Merck$3.6M
  • AstraZeneca$1.3M
  • Astrazeneca UK Limited$545K
  • Bayer$334K
  • Dendreon Pharmaceuticals LLC$177K
  • plus $311K from 54 others
$22,127in research payments, 2019–2025

Across 2 payments — averaging $11,063 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dendreon Pharmaceuticals LLC$22K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC737$5,883,018
Merck33$3,595,234
AstraZeneca15$1,283,802
Astrazeneca UK Limited6$545,477
Bayer34$333,931
Dendreon Pharmaceuticals LLC54$176,953
AbbVie(2 entities)39$96,784
Organon8$74,632
E.r. Squibb & Sons, L.L.C.1$44,652
Pfizer30$32,869
Veru Inc.11$24,833
Johnson & Johnson45$15,498
Janssen Scientific Affairs, LLC24$8,902
Urogen Pharma, Inc.8$2,895
GSK1$2,400
Telix Pharmaceuticals3$1,892
Urotronic, Inc1$1,235
Boston Scientific23$573
Astellas Pharma US Inc22$489
Endo Pharmaceuticals Inc.7$303
Sumitomo Pharma America, Inc.11$261
Myovant Sciences Inc.9$258
Axonics, Inc.9$238
Medtronic(2 entities)7$192
Antares Pharma, Inc.12$187
Neotract Inc.2$182
Procept Biorobotics Corporation1$165
Tolmar Pharmaceuticals, Inc.5$156
Ferring Pharmaceuticals Inc.7$151
Rochester Medical Corporation8$136
Tolmar, Inc.6$125
Convatec Inc.3$119
Coloplast4$91
Novartis3$90
Baxter Healthcare2$89
Teleflex LLC3$87
Progenics Pharmaceuticals, Inc.4$87
Blue Earth Diagnostics4$85
Endo USA, Inc.3$74
180 Medical, Inc.3$70
Sun Pharmaceutical Industries Inc.3$64
Ambu Inc.2$57
Hollister Incorporated2$47
Amgen2$38
C. R. Bard, Inc. & Subsidiaries1$36
Laborie Medical Technologies Corp.1$36
Caris MPI, Inc.1$35
Olympus America Inc.2$35
Cardinal Health 414 LLC1$31
Dentsply IH Inc.2$29
Myriad Genetic Laboratories, Inc.2$26
Innovation Technologies Inc1$21
Tempus AI, Inc1$21
Steris Corporation1$21
Photocure Inc1$19
Agiliti Surgical, Inc.1$19
Kowa Pharmaceuticals America, Inc.1$17
Travere Therapeutics, Inc.1$16
Biotissue Holdings Inc.1$15
Foundation Medicine, Inc.1$13

How this compares

$12,129,836 in reported general payments places this provider in the 95th percentile of 225 urology providers in Colorado.

See all urology providers in Colorado

Medicare billing

Part B allowed, 2024
$409,404
Medicare patients
361
Services billed
4,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Golden

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →